Quantitative radioimmunoPET imaging of EphA2 in tumor-bearing mice

[1] Cheng N(2002)The ephrins and Eph receptors in angiogenesis Cytokine Growth Factor Rev 13 75-85

[2] Brantley DM(2004)Eph receptor tyrosine kinases in tumor and tumor microenvironment Curr Pharm Des 10 3431-3442

[3] Chen J(1996)Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis Neuron 17 9-19

[4] Brantley-Sieders D(1998)Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4 Cell 93 741-753

[5] Schmidt S(2004)Expression of EphA2 and E-cadherin in colorectal cancer: correlation with cancer metastasis Oncol Rep 11 605-611

[6] Parker M(1999)Overexpression of the EphA2 tyrosine kinase in prostate cancer Prostate 41 275-280

[7] Chen J(2001)EphA2 overexpression causes tumorigenesis of mammary epithelial cells Cancer Res 61 2301-2306

[8] Gale NW(2004)EphA2 expression is associated with aggressive features in ovarian carcinoma Clin Cancer Res 10 5145-5150

[9] Holland SJ(2003)Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival Clin Cancer Res 9 613-618

[10] Valenzuela DM(2005)EphA2 receptor tyrosine kinase as a promising target for cancer therapeutics Curr Cancer Drug Targets 5 149-157

[1] Cheng N(2002)The ephrins and Eph receptors in angiogenesis Cytokine Growth Factor Rev 13 75-85

[2] Brantley DM(2004)Eph receptor tyrosine kinases in tumor and tumor microenvironment Curr Pharm Des 10 3431-3442

[3] Chen J(1996)Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis Neuron 17 9-19

[4] Brantley-Sieders D(1998)Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4 Cell 93 741-753

[5] Schmidt S(2004)Expression of EphA2 and E-cadherin in colorectal cancer: correlation with cancer metastasis Oncol Rep 11 605-611

[6] Parker M(1999)Overexpression of the EphA2 tyrosine kinase in prostate cancer Prostate 41 275-280

[7] Chen J(2001)EphA2 overexpression causes tumorigenesis of mammary epithelial cells Cancer Res 61 2301-2306

[8] Gale NW(2004)EphA2 expression is associated with aggressive features in ovarian carcinoma Clin Cancer Res 10 5145-5150

[9] Holland SJ(2003)Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival Clin Cancer Res 9 613-618

[10] Valenzuela DM(2005)EphA2 receptor tyrosine kinase as a promising target for cancer therapeutics Curr Cancer Drug Targets 5 149-157